Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis
- PMID: 33014519
- PMCID: PMC7505264
- DOI: 10.14336/AD.2019.1120
Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) is a fast progressing neurodegenerative disease leading to quadriplegia, anarthria and respiratory insufficiency. A large variety of phenotypes and disability progression requires individually tailored management. Identification of predictors of poor prognosis may not only improve management, but also allow for more precise patients' stratification for clinical trials or research studies. The aim of the study was to investigate the influence of emotional lability present at disease onset on ALS progression by exploring its direct impact on the decay of the ALS Functional Rating Scale-Revised (ALSFRS-R). The study was performed in a group of 1145 patients from Germany, Poland, Portugal and Turkey between 2014 and 2018. The analysis showed that the presence of emotional lability at ALS onset was linked to a faster decline of ALSFRS-R (0.70 vs 0.50, p<0.0001), in case of either bulbar (0.80 vs 0.65, p<0.05) or limb disease onset (0.59 vs 0.46, p <0.01). It was most prominent in the bulbar subscore of ALSFRS-R. A multiple regression analysis showed a direct influence of emotional lability at ALS onset on disease progression, regardless of age, gender, site of onset, weight loss, cognitive impairment and diagnosis delay (β=0.071; p=0.019). It can therefore be concluded that the presence of emotional lability at the disease onset is an independent factor of faster disease progression in ALS.
Keywords: amyotrophic lateral sclerosis; disease progression; emotional lability; epidemiology; pathological laughing and crying; prognosis; pseudobulbar affect.
copyright: © 2020 Barc et al.
Conflict of interest statement
Competing interests The authors state no conflict of interest.
Similar articles
-
What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry. 2017 May;88(5):381-385. doi: 10.1136/jnnp-2016-314661. Epub 2016 Nov 25. J Neurol Neurosurg Psychiatry. 2017. PMID: 27888187
-
[Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].Zhonghua Yi Xue Za Zhi. 2022 Jan 18;102(3):222-227. doi: 10.3760/cma.j.cn112137-20210728-01681. Zhonghua Yi Xue Za Zhi. 2022. PMID: 35042292 Chinese.
-
A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):206-211. doi: 10.1080/21678421.2017.1418001. Epub 2017 Dec 20. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29260911
-
Dextromethorphan/quinidine for the treatment of pseudobulbar affect.Consult Pharm. 2014 Apr;29(4):264-9. doi: 10.4140/TCP.n.2014.264. Consult Pharm. 2014. PMID: 24704895 Review.
-
Prognostic models for amyotrophic lateral sclerosis: a systematic review.J Neurol. 2021 Sep;268(9):3361-3370. doi: 10.1007/s00415-021-10508-7. Epub 2021 Mar 10. J Neurol. 2021. PMID: 33694050
Cited by
-
Resting state fMRI analysis of pseudobulbar affect in Amyotrophic Lateral Sclerosis (ALS): motor dysfunction of emotional expression.Brain Imaging Behav. 2023 Feb;17(1):77-89. doi: 10.1007/s11682-022-00744-4. Epub 2022 Nov 12. Brain Imaging Behav. 2023. PMID: 36370302 Free PMC article.
-
Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis.bioRxiv [Preprint]. 2024 Jun 1:2024.06.01.596819. doi: 10.1101/2024.06.01.596819. bioRxiv. 2024. PMID: 38854008 Free PMC article. Preprint.
-
Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology.Arq Neuropsiquiatr. 2023 Aug;81(8):764-775. doi: 10.1055/s-0043-1771176. Epub 2023 Aug 30. Arq Neuropsiquiatr. 2023. PMID: 37647907 Free PMC article.
-
cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders.Aging Dis. 2021 Oct 1;12(7):1658-1674. doi: 10.14336/AD.2021.0304. eCollection 2021 Oct. Aging Dis. 2021. PMID: 34631213 Free PMC article. Review.
-
Pathological laugher and crying in motor neuron diseases: a matter of bulbar and neurobehavioral involvement with sex imbalance.J Neurol. 2025 May 3;272(5):372. doi: 10.1007/s00415-025-12959-8. J Neurol. 2025. PMID: 40317297
References
-
- Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP (2017). Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry, 88(7):540-549. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous